182 related articles for article (PubMed ID: 5679524)
1. Use of drugs in the eye.
Ellis PP
GP; 1968 Oct; 38(4):99-108. PubMed ID: 5679524
[No Abstract] [Full Text] [Related]
2. [Kinetics of drugs in ophthalmology].
Lapalus P; Moulin G; Fredj D
Bull Soc Ophtalmol Fr; 1985 Nov; Spec No():31-48. PubMed ID: 2866043
[No Abstract] [Full Text] [Related]
3. [The use of magnetic fields in ophthalmology].
Skrinnik AV; Moiseeva NN
Oftalmol Zh; 1990; (8):492-6. PubMed ID: 2095478
[No Abstract] [Full Text] [Related]
4. [Homogeneous functional group, value--added tax, eye drops and ocular injections, personal computer and secundum artem].
Recio Blázquez ML
Farm Hosp; 2004; 28(4):291-3. PubMed ID: 15369440
[No Abstract] [Full Text] [Related]
5. Treatment of lacrimal deficiencies. Mechanical devices.
Doane MG
Int Ophthalmol Clin; 1973; 13(1):239-44. PubMed ID: 4724260
[No Abstract] [Full Text] [Related]
6. [Side effects of drugs in ophthalmology].
Polak BC; Henkes HE
Ned Tijdschr Geneeskd; 1987 Dec; 131(49):2254-7. PubMed ID: 3696257
[No Abstract] [Full Text] [Related]
7. Randomizing 1 eye or 2 eyes: a missed opportunity.
Glassman AR; Melia M
JAMA Ophthalmol; 2015 Jan; 133(1):9-10. PubMed ID: 25256889
[No Abstract] [Full Text] [Related]
8. Topical ophthalmic drugs and the pediatric patient.
Chung I; Buhr V
Optometry; 2000 Aug; 71(8):511-8. PubMed ID: 15326908
[TBL] [Abstract][Full Text] [Related]
9. Eyes on New Product Development.
Novack GD
J Ocul Pharmacol Ther; 2017 Mar; 33(2):65. PubMed ID: 28099041
[No Abstract] [Full Text] [Related]
10. Considerations for randomizing 1 eye or 2 eyes.
Bunce C; Wormald R
JAMA Ophthalmol; 2015 Oct; 133(10):1221. PubMed ID: 26291489
[No Abstract] [Full Text] [Related]
11. Considerations for randomizing 1 eye or 2 eyes--reply.
Glassman AR; Melia M
JAMA Ophthalmol; 2015 Oct; 133(10):1221. PubMed ID: 26291566
[No Abstract] [Full Text] [Related]
12. Drug delivery to the eye: current trends and future perspectives.
Behar-Cohen F
Ther Deliv; 2012 Oct; 3(10):1135-7. PubMed ID: 23116006
[No Abstract] [Full Text] [Related]
13. [Introduction of drugs into Tenon's space].
Remizov MS; Balueva LI
Vestn Oftalmol; 1973; 1():36-8. PubMed ID: 4777165
[No Abstract] [Full Text] [Related]
14. Preface.
Vavvas D; Gragoudas ES; Hatton MP
Int Ophthalmol Clin; 2004; 44(3):xiii. PubMed ID: 15211188
[No Abstract] [Full Text] [Related]
15. [10 years' experience using the suprachoroidal method of administering drugs].
Pen'kov MA; Avrushchenko NM
Oftalmol Zh; 1980; 35(5):281-5. PubMed ID: 7422215
[No Abstract] [Full Text] [Related]
16. Diffusional systems for controlled release of drugs to the eye.
Shell JW; Baker RW
Ann Ophthalmol; 1974 Oct; 6(10):1037-43, 1045. PubMed ID: 4429310
[No Abstract] [Full Text] [Related]
17. Side effects of systemic drugs on the eye and of ophthalmic drugs on the body.
el-Naggar AM; Khalil S
Bull Ophthalmol Soc Egypt; 1972; 65(69):563-6. PubMed ID: 4666816
[No Abstract] [Full Text] [Related]
18. Are contact lenses the solution for effective ophthalmic drug delivery?
Bengani L; Chauhan A
Future Med Chem; 2012 Nov; 4(17):2141-3. PubMed ID: 23190101
[No Abstract] [Full Text] [Related]
19. Ophthalmic preparations.
Phillips M
Nurs Mirror; 1982 Dec 22-29; 155(24 Spec No):69-71. PubMed ID: 6925825
[No Abstract] [Full Text] [Related]
20. Pharmaceutical Emulsions: A Viable Approach for Ocular Drug Delivery.
Bisen AC; Srivastava S; Mishra A; Sanap SN; Biswas A; Choudhury AD; Dubey A; Gupta NM; Yadav KS; Mugale MN; Bhatta RS
J Ocul Pharmacol Ther; 2024 Jun; 40(5):261-280. PubMed ID: 38654153
[No Abstract] [Full Text] [Related]
[Next] [New Search]
